Inactive Instrument

NIHON CHO Stock

3341

JP3729200000

NIHON CHOUZAI Co., Ltd is primarily engaged in the pharmacy business, the provision of staffing services, as well as the manufacture and sale of pharmaceutical products. The Company operates in three business segments. The Pharmacy segment is engaged in the operation of a chain of dispensing pharmacies. The Pharmaceutical Product Manufacturing and Distribution segment is engaged in the manufacture and nationwide sale of generic pharmaceutical products. The Healthcare Personnel Staffing Service segment is involved in the dispatching of pharmacists to various regional pharmacies.

Employees

6,063

Sector

Drug Retailers

More about the company

11-18	Nihon Chouzai Shareholders Approve Consolidation, Triggering Delisting	MT
15/10/25	Nihon Chouzai Co Ltd - to retire treasury shares worth 3.63% of outstanding stock on December 22, 2025	RE
29/09/25	NIHON CHOUZAI Co.,Ltd.(TSE:3341) dropped from S&P Global BMI Index	CI
17/09/25	AP86 to Become Parent as Nihon Chouzai Tender Offer Concludes	MT
16/09/25	Advantage Partners VII., Fund L.P managed by Advantage Partners, Inc. completed the acquisition of 72.80% stake in NIHON CHOUZAI Co.,Ltd. from Yosuke Mitsuhara, Hiroshi Mitsuhara, Yoko Mitsuhara, Keiko Yo and others for ¥85.7 billion.	CI
31/07/25	Advantage Partners VII., Fund L.P managed by Advantage Partners, Inc. proposed to acquire 80.52% stake in NIHON CHOUZAI Co.,Ltd. from Yosuke Mitsuhara, Hiroshi Mitsuhara, Yoko Mitsuhara, Keiko Yo and others for ¥94.8 billion.	CI
31/07/25	Nihon Chouzai Co Ltd - Notice regarding commencement of tender offer for shares of Nihon Chouzai Co., Ltd. (securities code 3341) by Ap86 Co., Ltd	RE
31/07/25	Nihon Chouzai Co.,Ltd. Omits Dividend for the Fiscal Year Ending March 2026	CI
29/07/25	Nihon Chouzai Confirms Privatization Talks With Advantage Partners, No Final Decision Yet	MT
28/07/25	Advantage Partners to take Nihon Chouzai private for over $674 mln, Nikkei says	RE
28/07/25	Nihon Chouzai to go private in deal worth over 100 billion yen, Nikkei says	RE
30/04/25	NIHON CHOUZAI Co.,Ltd. Provides Consolidated Earnings Guidance for the First Half and Full Year for the Fiscal Year Ending March 31, 2026	CI
30/04/25	NIHON CHOUZAI Co.,Ltd. Announces Dividend for the Fiscal Year Ended March 31, 2025, Payable on June 26, 2025 and Provides Dividend Guidance for the Second Quarter-End and Full Year of Fiscal Year Ending March 31, 2026	CI

04/06/24	Infosys collaborates with Nihon Chouzai to expand healthcare access in Japan	AQ
29/07/22	NIHON CHOUZAI : Results of Operations for the First Quarter of the Fiscal Year Ending March 31, 2023	PU
29/07/22	NIHON CHOUZAI : Summary of Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2023	PU
23/06/22	Nihon Chouzai : Notice Concerning a New Materiality Framework and Key Performance Indicators along with the Commencement of Information Disclosure Based on TCFD	PU
28/04/22	Nihon Chouzai : Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2022	PU

Manager	Title	Age	Since
Yoshimi Jun DFI	Director of Finance/CFO	-	-
Kazunori Ogi DFI	Director of Finance/CFO	59	01/04/2009
Taku Komata DFI	Director of Finance/CFO	-	25/06/2025

Director	Title	Age	Since
Toshiyuki Koyanagi BRD	Director/Board Member	63	01/06/2012
Kazunori Ogi BRD	Director/Board Member	59	25/06/2015
Yoshihisa Fujimoto BRD	Director/Board Member	68	01/06/2016

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
NIHON CHO	-0.38%	-0.13%	-	-	735M
RAIA DROGASIL S.A.	+9.77%	+3.21%	+17.98%	-25.21%	6.61B
AIN HOLDINGS INC.	-0.20%	-5.25%	-19.12%	+21.60%	1.3B
QOL HOLDINGS CO., LTD.	+0.85%	+7.21%	+16.97%	+23.34%	559M
MEDICAL IKKOU GROUP CO.,LTD.	+0.36%	-0.39%	-8.96%	+27.63%	67.61M
Average	+2.08%	-0.58%	+1.72%	+11.84%	2.13B
Weighted average by Cap.	+6.96%	-1.70%	+12.05%	-14.48%

NIHON CHO Stock

Stocks

3341

JP3729200000

Drug Retailers

Chart: NIHON CHO

Latest news: NIHON CHO

Press Releases: NIHON CHO

Quotes and Performance

Managers and Directors: NIHON CHO

Latest insider transactions

Retail - Drugs without Grocery

Company Profile